CorMedix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CorMedix and other ETFs, options, and stocks.

About CRMD

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. 

CEO
Joseph Todisco
CEOJoseph Todisco
Employees
65
Employees65
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
2006
Founded2006
Employees
65
Employees65

CRMD Key Statistics

Market cap
502.67M
Market cap502.67M
Price-Earnings ratio
3.47
Price-Earnings ratio3.47
Dividend yield
Dividend yield
Average volume
1.26M
Average volume1.26M
High today
$7.50
High today$7.50
Low today
$6.13
Low today$6.13
Open price
$6.31
Open price$6.31
Volume
1.70M
Volume1.70M
52 Week high
$17.43
52 Week high$17.43
52 Week low
$5.60
52 Week low$5.60

Stock Snapshot

With a market cap of 502.67M, CorMedix(CRMD) trades at $6.38. The stock has a price-to-earnings ratio of 3.47.

On 2026-03-05, CorMedix(CRMD) stock traded between a low of $6.13 and a high of $7.50. Shares are currently priced at $6.38, which is +4.1% above the low and -14.9% below the high.

The CorMedix(CRMD)'s current trading volume is 1.7M, compared to an average daily volume of 1.26M.

In the last year, CorMedix(CRMD) shares hit a 52-week high of $17.43 and a 52-week low of $5.60.

In the last year, CorMedix(CRMD) shares hit a 52-week high of $17.43 and a 52-week low of $5.60.

CRMD News

Nasdaq 3h
CorMedix Inc. Q4 Sales Increase

(RTTNews) - CorMedix Inc. (CRMD) released a profit for fourth quarter of $14.02 million The company's earnings totaled $14.02 million, or $0.16 per share. This...

CorMedix Inc. Q4 Sales Increase
TipRanks 3h
CorMedix reports Q4 EPS 16c vs 20c last year

Reports Q4 revenue $128.615M, consensus $127.02M. Joe Todisco, CorMedix (CRMD) Chairman and CEO, commented, “I am proud of the Company’s progress over the past...

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CRMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.